Bruker (BRKR) Income from Continuing Operations (2010 - 2026)
Bruker's (BRKR) quarterly Income from Continuing Operations came in at 19400000.0 in Q1 2026, up 18.29% YoY from 16400000.0 in Q1 2025, and up 104.69% on a QoQ basis from 413900000.0 in Q4 2025.
Bruker (BRKR) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Bruker (BRKR) has 17 years of Income from Continuing Operations data on file, last reported at 19400000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 18.29% year-over-year to 19400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 323700000.0 (up 3.63% YoY) and the FY2025 annual result came in at 451600000.0, down 68.07% from the prior year.
- Income from Continuing Operations climbed to 19400000.0 in Q1 2026, from 413900000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 177400000.0 in Q4 2023 to a low of 413900000.0 in Q4 2025.
- A 5-year average of 35435294.12 and a median of 30000000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 672.34% — and 2023, when it jumped 152.08%.
- Tracing BRKR's Income from Continuing Operations over 5 years: stood at 340600000.0 in 2022, then jumped by 152.08% to 177400000.0 in 2023, then plunged by 307.89% to 368800000.0 in 2024, then decreased by 12.23% to 413900000.0 in 2025, then surged by 104.69% to 19400000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 19400000.0 (Q1 2026), 413900000.0 (Q4 2025), and 73700000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Bruker | 9.22 Bn | 9.22 Bn | 416.00 Mn | -65.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -65.20 Mn |
| Mar 31, 2026 | 19.40 Mn |
| Dec 31, 2025 | -413.90 Mn |
| Sep 30, 2025 | 73.70 Mn |
| Jun 30, 2025 | -2.90 Mn |
| Mar 31, 2025 | 16.40 Mn |
| Dec 31, 2024 | -368.80 Mn |
| Sep 30, 2024 | 40.50 Mn |
| Jun 30, 2024 | -24.00 Mn |
| Mar 31, 2024 | -72.10 Mn |
| Dec 31, 2023 | 177.40 Mn |
| Sep 30, 2023 | 58.30 Mn |
| Jun 30, 2023 | 38.30 Mn |
| Mar 31, 2023 | 47.60 Mn |
| Dec 31, 2022 | -340.60 Mn |
| Sep 30, 2022 | 88.10 Mn |
| Jun 30, 2022 | 30.00 Mn |
| Mar 31, 2022 | 30.20 Mn |
| Dec 31, 2021 | -44.10 Mn |
| Sep 30, 2021 | 88.10 Mn |